Tokyo Tape
Sign in
← Fuji Pharma

Annual report

4554.TEDINET S100SI94
Period2022-10-01 → 2023-09-30
Filed2023-12-21
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
MetricValuePeriodScopeSource row
Revenue¥40.9bn2022-10-01 → 2023-09-30Cons.Net sales
Revenue¥35.4bn2021-10-01 → 2022-09-30Cons.Net sales
Revenue¥34.0bn2020-10-01 → 2021-09-30dCons.Net sales (5-year summary)
Revenue¥33.8bn2019-10-01 → 2020-09-30dCons.Net sales (5-year summary)
Revenue¥36.3bn2018-10-01 → 2019-09-30dCons.Net sales (5-year summary)
Operating income¥3.9bn2022-10-01 → 2023-09-30Cons.Operating income
Operating income¥3.8bn2021-10-01 → 2022-09-30Cons.Operating income
Ordinary income¥4.5bn2022-10-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥3.7bn2021-10-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥3.3bn2020-10-01 → 2021-09-30dCons.Ordinary income loss (5-year summary)
Ordinary income¥3.0bn2019-10-01 → 2020-09-30dCons.Ordinary income loss (5-year summary)
Ordinary income¥4.2bn2018-10-01 → 2019-09-30dCons.Ordinary income loss (5-year summary)
Profit before tax¥4.4bn2022-10-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥3.7bn2021-10-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥3.4bn2022-10-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.7bn2021-10-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.4bn2020-10-01 → 2021-09-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.1bn2019-10-01 → 2020-09-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥3.0bn2018-10-01 → 2019-09-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥3.4bn2022-10-01 → 2023-09-30Cons.Profit loss
Net income¥2.7bn2021-10-01 → 2022-09-30Cons.Profit loss
Total assets¥85.3bnat 2023-09-30Cons.Assets
Total assets¥75.5bnat 2022-09-30Cons.Assets
Total assets¥64.2bnat 2021-09-30dCons.Total assets (5-year summary)
Total assets¥62.0bnat 2020-09-30dCons.Total assets (5-year summary)
Total assets¥60.7bnat 2019-09-30dCons.Total assets (5-year summary)
Total liabilities¥44.2bnat 2023-09-30Cons.Liabilities
Total liabilities¥39.7bnat 2022-09-30Cons.Liabilities
Net assets / equity¥41.2bnat 2023-09-30Cons.Net assets
Net assets / equity¥35.8bnat 2022-09-30Cons.Net assets
Net assets / equity¥32.7bnat 2021-09-30dCons.Net assets
Net assets / equity¥40.0bnat 2020-09-30dCons.Net assets (5-year summary)
Net assets / equity¥39.4bnat 2019-09-30dCons.Net assets (5-year summary)
Cash and deposits¥2.3bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥3.5bnat 2022-09-30Cons.Cash and deposits
Cash & equivalents¥2.3bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥3.5bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥10.2bnat 2021-09-30dCons.Cash and cash equivalents
Cash & equivalents¥12.0bnat 2020-09-30dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥8.5bnat 2019-09-30dCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥1.9bn2022-10-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥658m2021-10-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥6.0bn2020-10-01 → 2021-09-30dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥5.8bn2019-10-01 → 2020-09-30dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥7.0bn2018-10-01 → 2019-09-30dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥5.2bn2022-10-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥11.3bn2021-10-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥2.3bn2020-10-01 → 2021-09-30dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥2.6bn2019-10-01 → 2020-09-30dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥12.0bn2018-10-01 → 2019-09-30dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow¥1.9bn2022-10-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥5.1bn2021-10-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥5.4bn2020-10-01 → 2021-09-30dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥450m2019-10-01 → 2020-09-30dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥7.3bn2018-10-01 → 2019-09-30dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥141.372022-10-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥111.012021-10-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥90.542020-10-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥66.942019-10-01 → 2020-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥97.042018-10-01 → 2019-09-30dCons.Basic earnings loss per share (5-year summary)
Net assets per share¥1,694.23at 2023-09-30Cons.Net assets per share (5-year summary)
Net assets per share¥1,473.73at 2022-09-30Cons.Net assets per share (5-year summary)
Net assets per share¥1,345.56at 2021-09-30dCons.Net assets per share (5-year summary)
Net assets per share¥1,282.43at 2020-09-30dCons.Net assets per share (5-year summary)
Net assets per share¥1,263.51at 2019-09-30dCons.Net assets per share (5-year summary)
Equity ratio48.3%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio47.4%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio50.9%at 2021-09-30dCons.Equity to asset ratio (5-year summary)
Equity ratio64.5%at 2020-09-30dCons.Equity to asset ratio (5-year summary)
Equity ratio64.8%at 2019-09-30dCons.Equity to asset ratio (5-year summary)
ROE8.9%2022-10-01 → 2023-09-30Cons.Rate of return on equity (5-year summary)
ROE7.9%2021-10-01 → 2022-09-30Cons.Rate of return on equity (5-year summary)
ROE6.7%2020-10-01 → 2021-09-30dCons.Rate of return on equity (5-year summary)
ROE5.3%2019-10-01 → 2020-09-30dCons.Rate of return on equity (5-year summary)
ROE7.9%2018-10-01 → 2019-09-30dCons.Rate of return on equity (5-year summary)
Employees1,621at 2023-09-30Cons.Number of employees
Employees1,560at 2022-09-30Cons.Number of employees
Employees1,532at 2021-09-30dCons.Number of employees
Employees1,550at 2020-09-30dCons.Number of employees
Employees1,527at 2019-09-30dCons.Number of employees
Revenue¥37.4bn2022-10-01 → 2023-09-30StandaloneNet sales
Revenue¥32.6bn2021-10-01 → 2022-09-30StandaloneNet sales
Revenue¥31.9bn2020-10-01 → 2021-09-30dStandaloneNet sales (5-year summary)
Revenue¥31.3bn2019-10-01 → 2020-09-30dStandaloneNet sales (5-year summary)
Revenue¥33.7bn2018-10-01 → 2019-09-30dStandaloneNet sales (5-year summary)
Operating income¥3.5bn2022-10-01 → 2023-09-30StandaloneOperating income
Operating income¥3.5bn2021-10-01 → 2022-09-30StandaloneOperating income
Ordinary income¥4.1bn2022-10-01 → 2023-09-30StandaloneOrdinary income
Ordinary income¥3.4bn2021-10-01 → 2022-09-30StandaloneOrdinary income
Ordinary income¥3.3bn2020-10-01 → 2021-09-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥2.8bn2019-10-01 → 2020-09-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥4.0bn2018-10-01 → 2019-09-30dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥4.0bn2022-10-01 → 2023-09-30StandaloneIncome before income taxes
Profit before tax¥3.4bn2021-10-01 → 2022-09-30StandaloneIncome before income taxes
Net income¥3.1bn2022-10-01 → 2023-09-30StandaloneProfit loss
Net income¥2.5bn2021-10-01 → 2022-09-30StandaloneProfit loss
Net income¥2.6bn2020-10-01 → 2021-09-30dStandaloneNet income loss (5-year summary)
Net income¥2.0bn2019-10-01 → 2020-09-30dStandaloneNet income loss (5-year summary)
Net income¥2.8bn2018-10-01 → 2019-09-30dStandaloneNet income loss (5-year summary)
Total assets¥80.0bnat 2023-09-30StandaloneAssets
Total assets¥71.3bnat 2022-09-30StandaloneAssets
Total assets¥62.1bnat 2021-09-30dStandaloneTotal assets (5-year summary)
Total assets¥59.3bnat 2020-09-30dStandaloneTotal assets (5-year summary)
Total assets¥57.4bnat 2019-09-30dStandaloneTotal assets (5-year summary)
Total liabilities¥41.0bnat 2023-09-30StandaloneLiabilities
Total liabilities¥36.8bnat 2022-09-30StandaloneLiabilities
Net assets / equity¥39.0bnat 2023-09-30StandaloneNet assets
Net assets / equity¥34.5bnat 2022-09-30StandaloneNet assets
Net assets / equity¥32.6bnat 2021-09-30dStandaloneNet assets
Net assets / equity¥39.6bnat 2020-09-30dStandaloneNet assets (5-year summary)
Net assets / equity¥38.8bnat 2019-09-30dStandaloneNet assets (5-year summary)
Cash and deposits¥1.2bnat 2023-09-30StandaloneCash and deposits
Cash and deposits¥2.7bnat 2022-09-30StandaloneCash and deposits
EPS (basic)¥128.272022-10-01 → 2023-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥102.12021-10-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥95.12020-10-01 → 2021-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥64.72019-10-01 → 2020-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥93.12018-10-01 → 2019-09-30dStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥372022-10-01 → 2023-09-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥352021-10-01 → 2022-09-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥292020-10-01 → 2021-09-30dStandaloneDividend paid per share (5-year summary)
Dividend per share¥292019-10-01 → 2020-09-30dStandaloneDividend paid per share (5-year summary)
Dividend per share¥292018-10-01 → 2019-09-30dStandaloneDividend paid per share (5-year summary)
Net assets per share¥1,603.83at 2023-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥1,420.42at 2022-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥1,342.1at 2021-09-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥1,270.79at 2020-09-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥1,245.03at 2019-09-30dStandaloneNet assets per share (5-year summary)
Equity ratio48.7%at 2023-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio48.4%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio52.5%at 2021-09-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio66.8%at 2020-09-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio67.6%at 2019-09-30dStandaloneEquity to asset ratio (5-year summary)
ROE8.5%2022-10-01 → 2023-09-30StandaloneRate of return on equity (5-year summary)
ROE7.4%2021-10-01 → 2022-09-30StandaloneRate of return on equity (5-year summary)
ROE7.1%2020-10-01 → 2021-09-30dStandaloneRate of return on equity (5-year summary)
ROE5.1%2019-10-01 → 2020-09-30dStandaloneRate of return on equity (5-year summary)
ROE7.7%2018-10-01 → 2019-09-30dStandaloneRate of return on equity (5-year summary)
Shares issued24,753,800at 2023-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued24,753,800at 2022-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued24,753,800at 2021-09-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued31,253,800at 2020-09-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued31,253,800at 2019-09-30dStandaloneTotal number of issued shares (5-year summary)
Employees866at 2023-09-30StandaloneNumber of employees
Employees817at 2022-09-30StandaloneNumber of employees
Employees791at 2021-09-30dStandaloneNumber of employees
Employees779at 2020-09-30dStandaloneNumber of employees
Employees761at 2019-09-30dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 1,541
ItemContextValueUnit
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember2240000000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember2240000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_TreasuryStockMember11000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_ShareholdersEquityMember2228000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember2253000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_DeferredGainsOrLossesOnHedgesMember-13000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember2240000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember4469000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_TreasuryStockMember-567000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ShareholdersEquityMember36560000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember2414000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_DeferredGainsOrLossesOnHedgesMember2000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember2417000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember38977000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-12-21
Fiscal year cover pageFilingDateInstant
Original text (Japanese)第59期(自　2022年10月１日　至　2023年９月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)富士製薬工業株式会社
Company name in english cover pageFilingDateInstantFuji Pharma Co.,Ltd.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　岩井　孝之
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都千代田区三番町５番地７
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)03(3556)3344(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)執行役員　経営管理部長　　宇治　浩
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都千代田区三番町５番地７
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03(3556)3344(代表)
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)執行役員　経営管理部長　　宇治　浩
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE00975
Fund codeFilingDateInstant－
Security codeFilingDateInstant45540
Filer name in japaneseFilingDateInstant
Original text (Japanese)富士製薬工業株式会社
Filer name in englishFilingDateInstantFuji Pharma Co.,Ltd.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第三号様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstanttrue
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstantcte
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstantcte
Current fiscal year start dateFilingDateInstant2022-10-01
Current period end dateFilingDateInstant2023-09-30
Type of current periodFilingDateInstantFY
Current fiscal year end dateFilingDateInstant2023-09-30
Previous fiscal year start dateFilingDateInstant2021-10-01
Comparative period end dateFilingDateInstant2022-09-30
Previous fiscal year end dateFilingDateInstant2022-09-30
Next fiscal year start dateFilingDateInstant－

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2022-09-30pass
balance sheet identityconsolidated 2023-09-30pass
balance sheet identitynon_consolidated 2022-09-30pass rounding
balance sheet identitynon_consolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2021-09-30pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net assetsnon_consolidated 2021-09-30pass
statement vs summary · net assetsnon_consolidated 2022-09-30pass
statement vs summary · net assetsnon_consolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-10-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2021-10-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2022-10-01/2023-09-30pass
statement vs summary · revenueconsolidated 2021-10-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-10-01/2023-09-30pass
statement vs summary · revenuenon_consolidated 2021-10-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2022-10-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2022-09-30pass
statement vs summary · total assetsconsolidated 2023-09-30pass
statement vs summary · total assetsnon_consolidated 2022-09-30pass
statement vs summary · total assetsnon_consolidated 2023-09-30pass